Clinical Trials Browser

Phase 1 × Fluoxetine × Gastrointestinal × Clear all

NCT06225011 2025-05-13

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Phase 1 Recruiting

Gastrointestinal

Colorectal Adenocarcinoma